WNY Asset Management
HQL icon

WNY Asset Management’s abrdn Life Sciences Investors HQL Stock Holding History

WNY Asset Management’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,710
Closed -$239K – 266
2026
Q1 		$239K Buy
+14,710
New +$246K 0.02% 226
2025
Q3 		$399K Buy
25,704
+749
+3% +$10.3K 0.04% 163
2025
Q2 		$320K Buy
24,955
+821
+3% +$10.1K 0.04% 174
2025
Q1 		$306K Buy
24,134
+2,988
+14% +$40.5K 0.04% 180
2024
Q4 		$277K Hold
21,146
– – 0.03% 182
2024
Q3 		$319K Buy
+21,146
New +$320K 0.04% 179

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Penserra Capital Management
Penserra Capital Management Orinda, California $13B AUM 71.83% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Needham Investment Management
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
Flagship Harbor Advisors
Flagship Harbor Advisors Boston, Massachusetts $2.69B AUM 15.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Advisors Asset Management
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
180 Wealth Advisors
180 Wealth Advisors Federal Way, Washington $1.04B AUM 41.44% 1-Year Est. Return

WNY Asset Management's HQL Position: Q2 2026 in Review

WNY Asset Management sold out of abrdn Life Sciences Investors (HQL) in Q2 2026, closing a stake of 14,710 shares — an estimated $239K sold.

WNY Asset Management first reported a position in HQL in Q3 2024 and held it in 6 quarters. The position peaked at $399K in Q3 2025. 85 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • WNY Asset Management reported no remaining abrdn Life Sciences Investors position as of Q2 2026 after selling out during the quarter.
  • WNY Asset Management sold 14,710 abrdn Life Sciences Investors shares in Q2 2026, an estimated $239K.
  • WNY Asset Management first reported a position in abrdn Life Sciences Investors in Q3 2024 and held it in 6 quarters.
  • WNY Asset Management's abrdn Life Sciences Investors position peaked at $399K in Q3 2025.
  • 85 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on WNY Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.